HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sai Mao Selected Research

Infections

1/2024CCCP inhibits DPV infection in DEF cells by attenuating DPV manipulated ROS, apoptosis, and mitochondrial stability.
12/2023Decoding the enigma: unveiling the molecular transmission of avian-associated tet(X4)-positive E. coli in Sichuan Province, China.
12/2023Functional characterization of two TolC in the resistance to drugs and metals and in the virulence of Riemerella anatipestifer.
11/2023Duck Tembusu virus NS3 protein induces apoptosis by activating the PERK/PKR pathway and mitochondrial pathway.
11/2023NS5 hijacks TRAF3 to inhibit type I interferon signaling during duck Tembusu virus infection.
9/2023miR-146b-5p promotes duck Tembusu virus replication by targeting RPS14.
5/2023Establishment and application of a PCR assay for the identification of virulent and attenuated duck plague virus DNA in cotton swabs.
4/2023Duck IL-7 as a novel adjuvant improves the humoral immune response to an inactivated duck tembusu virus vaccine.
3/2023Evaluation of the immunoprotection efficacy of Riemerella anatipestifer fur-deficient mutant as an attenuated vaccine.
1/2023DHAV 3CD targets IRF7 and RIG-I proteins to block the type I interferon upstream signaling pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sai Mao Research Topics

Disease

36Infections
01/2024 - 01/2017
23Plague (Bubonic Plague)
01/2024 - 01/2020
11Virus Diseases (Viral Diseases)
11/2023 - 09/2019
5Enteritis
01/2021 - 01/2019
3Viremia
05/2022 - 05/2015
2Bites and Stings (Sting)
03/2022 - 05/2021
2Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2021 - 01/2020
1Atrophy
01/2023
1Flavivirus Infections
01/2023
1Weight Loss (Weight Reduction)
10/2022
1Melanoma (Melanoma, Malignant)
03/2022
1Cholera
03/2022
1Inflammation (Inflammations)
01/2022
1Vesicular Stomatitis
05/2021
1Neoplasms (Cancer)
01/2021
1Herpes Simplex
01/2020
1Latent Infection
01/2019

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
05/2023 - 01/2019
12Antiviral Agents (Antivirals)IBA
01/2024 - 01/2019
10VaccinesIBA
05/2023 - 01/2021
6Viral ProteinsIBA
11/2022 - 01/2020
6Messenger RNA (mRNA)IBA
07/2022 - 09/2020
5butyl phosphorotrithioate (DEF)IBA
01/2024 - 01/2020
5Interferon Type IIBA
11/2023 - 01/2020
5CytokinesIBA
01/2022 - 01/2017
4InterferonsIBA
11/2023 - 05/2021
4DNA (Deoxyribonucleic Acid)IBA
05/2023 - 05/2021
4Phosphotransferases (Kinase)IBA
05/2023 - 01/2020
4RNA (Ribonucleic Acid)IBA
07/2022 - 09/2020
3Glycoproteins (Glycoprotein)IBA
05/2023 - 12/2020
3Protein Kinases (Protein Kinase)IBA
03/2023 - 01/2021
3AntibodiesIBA
05/2022 - 05/2015
3Attenuated VaccinesIBA
03/2022 - 01/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 07/2022
2Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 12/2022
2Etoposide (VP 16)FDA LinkGeneric
02/2023 - 01/2020
2Toll-Like Receptor 3IBA
01/2023 - 01/2022
2Caspase 3 (Caspase-3)IBA
07/2022 - 01/2022
2Peptide Hydrolases (Proteases)FDA Link
01/2022 - 01/2019
2Staphylococcal Protein A (Protein A)IBA
01/2021 - 01/2020
1Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA
01/2024
1Tigecycline (Tygacil)FDA Link
12/2023
1TNF Receptor-Associated Factor 3IBA
11/2023
1MicroRNAs (MicroRNA)IBA
09/2023
1Viral DNAIBA
05/2023
1BX795IBA
05/2023
1Factor VII (Proconvertin)IBA
01/2023
1Marker VaccinesIBA
01/2023
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2023
1Toll-Like Receptor 4IBA
12/2022
1LipopolysaccharidesIBA
12/2022
13' Untranslated Regions (3' UTR)IBA
10/2022
1RNA CapsIBA
09/2022
1Long Noncoding RNAIBA
07/2022
1Matrix Metalloproteinases (MMPs)IBA
07/2022
1Apoptosis Regulatory ProteinsIBA
07/2022
1Cytochromes c (Cytochrome c)IBA
07/2022
1Death Domain ReceptorsIBA
07/2022
1Interferon Regulatory FactorsIBA
03/2022
1Poly I-CIBA
01/2022
1Suppressor of Cytokine Signaling 1 ProteinIBA
01/2022
16-methyladenineIBA
01/2022
1CaspasesIBA
01/2022
1Granzymes (Granzyme)IBA
01/2022
1Neutralizing AntibodiesIBA
01/2022
1Interleukin-2 (IL2)IBA
11/2021
1Interleukin-4 (Interleukin 4)IBA
11/2021
1SC75741IBA
05/2021
1Nuclear Localization Signals (Nuclear Localization Signal)IBA
01/2021
1Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
01/2021
1Interleukin-7 (Interleukin 7)IBA
01/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1LipidsIBA
01/2021
1PolyubiquitinIBA
01/2020
1Carrier Proteins (Binding Protein)IBA
01/2020
1Gold Colloid (Colloidal Gold)IBA
01/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020
1messenger ribonucleoproteinIBA
01/2020
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2020
1Viral RNAIBA
01/2020
1Suppressor of Cytokine Signaling ProteinsIBA
01/2020
1Nucleic AcidsIBA
01/2020
1Pattern Recognition ReceptorsIBA
01/2017

Therapy/Procedure

2Therapeutics
12/2023 - 09/2020
1Intravenous Injections
01/2020